On March 2, 2023, Centers for Medicare and Medicaid Services (CMS) announced expanded Continuous Glucose Monitor (CGM) coverage. Find answers to some of the most frequently asked questions about this change.
If you or your patients have Medicare, new changes allow greater access to a CGM devices. Medicare beneficiaries with diabetes may be eligible if they:
This is effective as of April 16, 2023.
There are no requirements as to the type of insulin you take or how much, you just need to be prescribed insulin as a form of treatment for your diabetes.
It does not matter what type of diabetes you have, just as long as you have a diabetes diagnosis and are taking insulin.
No. The CMS will cover your CGM device as long as it is FDA-approved.
You can find more information on this specific change on the CMS website and on this webpage.
We recommend you begin by speaking to your health care provider to see if using a CGM is a good option for you.